This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches

Read more

  • Cooperation studies on inherited susceptibility to colorectal cancer
  • Graphic



Barcelona (Spain)

June 1-3, 2022

Final TRANSCOLONCAN meeting 2022

Final meeting of the Action. It will include a MC+WG meeting the first day and subsequent 2-day workshop open to the entire scientific community showcasing the achieved results from this network.

The workshop has the tentative title "Identification of biomarkers for colorectal cancer - a translational workshop from the TRANSCOLONCAN network".

More about "Final TRANSCOLONCAN meeting 2022"

COST is supported by the EU Framework Programme Horizon 2020